Manufacturers’ Group Is Not Satisfied With FDA In-Vitro Diagnostics Office
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic manufacturers have not seen the improved review times they expected from the founding of the Office of In Vitro Diagnostic Device Evaluation & Safety (OIVD) in 2002, according to the chief counsel for the Association of Medical Diagnostic Manufacturers (AMDM)